Evidence map›Paper›PMID 33411073›Full record

ArticlePediatric nephrology (Berlin, Germany)2021

Reduced urinary excretion of neutrophil gelatinase-associated lipocalin as a risk factor for recurrence of febrile urinary tract infection in children.

Sohsaku Yamanouchi, Takahisa Kimata, Yuko Akagawa, Shohei Akagawa, Jiro Kino, Shoji Tsuji, Kazunari Kaneko

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sohsaku YamanouchiDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan.
Takahisa KimataDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan.
Yuko AkagawaDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan.
Shohei AkagawaDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan.
Jiro KinoDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan.
Shoji TsujiDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan.
Kazunari KanekoDepartment of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 5731010, Japan. kanekok@hirakata.kmu.ac.jp.ORCID 0000-0003-3607-8355
Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to test the hypothesis that reduced urinary excretions of neutrophil gelatinase-associated lipocalin (NGAL) predispose children to recurrence of febrile urinary tract infection (fUTI).

methodsSubjects were 38 children diagnosed with fUTI. To examine risk factors for recurrence of fUTI, the subjects were divided into a non-recurrent group and a recurrent group according to the presence or absence of fUTI over 3 years since the first episode. We measured the urinary NGAL levels in patients with fUTI at the non-infected stage in addition to age-matched healthy control children.

resultsIn a multiple logistic regression analysis, significant differences between the groups were not observed for age, sex, the prevalence of kidney scarring and bladder bowel dysfunction, urinary β2-microglobulin/creatinine (Cr) level, and serum levels of Cr and Cystatin C, while the recurrent group had significantly more cases with grade III or higher vesicoureteral reflux (p < 0.01). Furthermore, the urinary NGAL/Cr in the recurrent group (median, 3.60 μg/gCr) was significantly lower than that in the non-recurrent group (median, 16.47 μg/gCr; p < 0.01), and age-matched healthy control children (median, 14.14 μg/gCr; p < 0.05). The area under the receiver operating characteristic curve of NGAL/Cr was 0.86 for predicting recurrence of fUTI. A cut-off value of 11.59 μg/gCr had the best accuracy to predict recurrent fUTI yielding a specificity of 78% and a sensitivity of 93%.

conclusionsReduced levels of urinary NGAL, which protects against urinary infection, are a risk factor for recurrence of fUTI and could serve as a biomarker.

Indexed as

Urinary Tract InfectionsBiomarkersChildFeverHumansLipocalin-2Risk FactorsVesico-Ureteral RefluxBiomarkersLipocalin-299m-technetium dimercaptosuccinic acid renal scintigraphyAntibacterial peptideChildrenFebrile urinary tract infectionsNeutrophil gelatinase-associated lipocalinRecurrenceVesicoureteral reflux

Identifiers

PMID33411073
OpenAlexW3119547053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.